Internal Medicine · Houston, TX
NPI
1609025865
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
1515 Holcombe Blvd
Houston, TX, 77030
Phone (713) 792-6161
Groups this clinician bills Medicare through
Medicare paid, 2024
$52K
439 services
Medicare patients, 2024
89
Average age 71
Drug cost, 2024
$418K
120 prescriptions
Company payments, 2025
$3,163
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shumei Kato was code 99215 (office e&m - established), 218 times for 55 patients. In total Shumei Kato billed 439 services in 8 codes, and Medicare paid $52K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 218 | 55 | $111.42 | $24K |
| 99215 Office E&M - Established | Office | 139 | 45 | $147.18 | $20K |
| 99498 Care Management/Coordination | Facility | 30 | 17 | $57.64 | $1,729 |
| 99205 Office E&M - New | Facility | 22 | 22 | $146.15 | $3,215 |
| 99497 Care Management/Coordination | Facility | 20 | 20 | $61.23 | $1,225 |
By year: 2022 $49K for 451 services; 2023 $49K for 454 services; 2024 $52K for 439 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shumei Kato prescribed most often to Medicare patients was Prochlorperazine Maleate, with 19 prescriptions and refills. In total Shumei Kato wrote 120 Medicare prescriptions that cost $418K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prochlorperazine Maleate Generic | 19 | 19 | 16 | $190 |
| Ondansetron Hcl Generic | 17 | 17 | 14 | $190 |
| Balversa Erdafitinib | 12 | 13 | Under 11 | $167K |
| Potassium Chloride Generic | 11 | 11 | Under 11 | $65.3 |
Brand drugs: 30 claims; generic drugs: 90 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shumei Kato $3,163 ($3,163 in general payments such as food, travel and fees) from 5 companies. The largest payer was Partner Therapeutics, Inc. with $3,163.
| Company | Payments | Amount |
|---|---|---|
| Partner Therapeutics, Inc. | 2 | $3,163 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.